Treatment Refusal
9
2
2
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.1%
1 terminated out of 9 trials
80.0%
-6.5% vs benchmark
0%
0 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (9)
Facilitators and Barriers to Eptinezumab Administration in Thailand
Culturally Aware AET Non-Initiation Intervention
Assessment of Emotion Regulation Strategies Used When Suicidal
PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma
Behavioral Economics Intervention to Increase Treatment Seeking in the National Guard
The Registry Study of Takayasu Arteritis in East China
"Sandwich" Chemotherapy With Radiotherapy in Newly Diagnosed, Stage IE to IIE, ENKTL
Individual vs. Group Community Reinforcement Training to Help Parents of Substance-using Treatment-refusing Youth
Survey of Adherence to Immunosuppression and Other Medications in Kidney Transplant Patients